BioNTech raises $270M series A

Immuno-oncology company BioNTech AG (Mainz, Germany) raised $270 million in a series A round led by new investor Redmile Group. Other new investors included Janus Henderson Investors, Invus, Fidelity and several undisclosed European family offices. The Strüngmann family office, a founding investor of BioNTech and majority shareholder, also participated in the round.

BioNTech COO Sean Marett told BioCentury the capital will primarily fund development of the company's clinical pipeline and expansion of manufacturing facilities...